Christina Trojel-Hansen is the founder of Pretzel Therapeutics. Pretzel Therapeutics has raised $73M in total funding. Latest round: Series A.
Christina Trojel-Hansen is a biotechnology executive known for her leadership in the early spin-out of Pretzel Therapeutics. She has also guided grant applications and early company formation for other ventures, including Oscine (acquired) and Adcendo.
Full founder directory · Investor directory · Company funding database · Fundraising library